Literature DB >> 11167868

Treatment of ruptured hepatocellular adenoma.

T Terkivatan1, J H de Wilt, R A de Man, R R van Rijn, H W Tilanus, J N IJzermans.   

Abstract

BACKGROUND: As the morbidity and mortality rates associated with emergency resection in patients with a ruptured hepatocellular adenoma are high, the authors have favoured initial non-operative management in haemodynamically stable patients.
METHODS: A retrospective study was performed to evaluate the treatment of ruptured hepatocellular adenoma.
RESULTS: Over a 21-year interval, 12 patients presented with a ruptured hepatocellular adenoma. Haemodynamic observation and support was the initial management in all 12 patients. Three underwent urgent laparotomy and gauze packing because of haemodynamic instability; no emergency liver resection was necessary. Eight patients had definitive surgery; three developed postoperative complications but none died. Regression of the tumour was observed in three of four patients treated conservatively.
CONCLUSION: The initial management of a ruptured hepatocellular adenoma should be haemodynamic stabilization. Definitive resection is required for rebleeding or for tumours exceeding 5 cm in diameter. A conservative approach may well be justified in case of regression of an asymptomatic adenoma.

Entities:  

Mesh:

Year:  2001        PMID: 11167868     DOI: 10.1046/j.1365-2168.2001.01648.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  22 in total

1.  Etiology and management of hemmorrhage in spontaneous liver rupture: a report of 70 cases.

Authors:  Zhe-Yu Chen; Qing-Hui Qi; Zuo-Liang Dong
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

Review 2.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

3.  Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit.

Authors:  Nicola de'Angelis; Riccardo Memeo; Julien Calderaro; Emanuele Felli; Chady Salloum; Philippe Compagnon; Alain Luciani; Alexis Laurent; Daniel Cherqui; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2014-05-23       Impact factor: 3.647

Review 4.  Hepatocellular adenoma management: advances but still a long way to go.

Authors:  Jean Frédéric Blanc; Nora Frulio; Laurence Chiche; Paulette Bioulac-Sage; Charles Balabaud
Journal:  Hepat Oncol       Date:  2015-05-15

Review 5.  Benign solid tumors of the liver: management in the modern era.

Authors:  Georgios Antonios Margonis; Aslam Ejaz; Gaya Spolverato; Neda Rastegar; Robert Anders; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-01-06       Impact factor: 3.452

6.  Laparoscopic liver resection for hepatocellular adenoma.

Authors:  Mohammed Abu Hilal; Francesco Di Fabio; Robert David Wiltshire; Mohammed Hamdan; David M Layfield; Neil William Pearce
Journal:  World J Gastrointest Surg       Date:  2011-07-27

7.  LATE SURGICAL TREATMENT FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR ADENOMA: CASE REPORT.

Authors:  Luis Eduardo Veras Pinto; João Paulo Ribeiro Silva; Gustavo Coêlho Rêgo; José Huygens Parente Garcia
Journal:  Arq Bras Cir Dig       Date:  2015 Nov-Dec

8.  PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions.

Authors:  Ser Yee Lee; T Peter Kingham; Maria D LaGratta; Jose Jessurun; Daniel Cherqui; William R Jarnagin; Michael D Kluger
Journal:  HPB (Oxford)       Date:  2015-12-11       Impact factor: 3.647

9.  Liver cell adenoma and liver cell adenomatosis.

Authors:  Ludger Barthelmes; Iain S Tait
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

10.  Surgical management of spontaneous ruptured hepatocellular adenoma.

Authors:  Marcelo Augusto Fontenelle Ribeiro Junior; Eleazar Chaib; William Abrão Saad; Luiz Augusto Carneiro D'Albuquerque; Ivan Cecconello
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.